Long term follow up of patients treated for Helicobacter pylori infection

被引:259
作者
Mera, R
Fontham, ETH
Bravo, LE
Bravo, JC
Piazuelo, MB
Camargo, MC
Correa, P
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA 70112 USA
[3] Univ Valle, Dept Pathol, Cali, Colombia
关键词
D O I
10.1136/gut.2005.072009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Helicobacter pylori infection induces progressive inflammatory changes in the gastric mucosa that may lead to gastric cancer. Understanding long term effects resulting from the cure of this infection is needed to design cancer prevention strategies. Methods: A cohort of 795 adults with preneoplastic gastric lesions was randomised to receive anti-H pylori treatment and/or antioxidants. At the end of six years of intervention, those who did not receive anti-H pylori treatment were offered it. Gastric biopsies were obtained at baseline, and at 3, 6, and 12 years. A histopathology score was utilised to document changes in gastric lesions. Non-linear mixed models were used to estimate the cumulative effect of H pylori clearance on histopathology scores adjusted for follow up time, interventions, and confounders. Results: Ninety seven per cent of subjects were H pylori positive at baseline, and 53% were positive at 12 years. Subjects accumulated 1703 person years free of infection. A multivariate model showed a significant regression in histopathology score as a function of the square of H pylori negative time. Subjects who were H pylori negative had 14.8% more regression and 13.7% less progression than patients who were positive at 12 years (p = 0.001). The rate of healing of gastric lesions occurred more rapidly as years free of infection accumulated, and was more pronounced in less advanced lesions. Conclusions: Preneoplastic gastric lesions regress at a rate equal to the square of time in patients rendered free of H pylori infection. Our findings suggest that patients with preneoplastic gastric lesions should be treated and cured of their H pylori infection.
引用
收藏
页码:1536 / 1540
页数:5
相关论文
共 37 条
[21]   Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated [J].
Ohkusa, T ;
Fujiki, K ;
Takashimizu, I ;
Kumagai, J ;
Tanizawa, T ;
Eishi, Y ;
Yokoyama, T ;
Watanabe, M .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :380-386
[22]   Gastric dysplasia - The Padova international classification [J].
Rugge, M ;
Correa, P ;
Dixon, MF ;
Hattori, T ;
Leandro, G ;
Lewin, K ;
Riddell, RH ;
Sipponen, P ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (02) :167-176
[23]   Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading [J].
Rugge, M ;
Correa, P ;
Dixon, MF ;
Fiocca, R ;
Hattori, T ;
Lechago, J ;
Leandro, G ;
Price, AB ;
Sipponen, P ;
Solcia, E ;
Watanabe, H ;
Genta, RM .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) :1249-1259
[24]  
SIPPONEN P, 1985, INT J CANCER, V35, P173
[25]   Atrophy and intestinal metaplasia one year after cure of H-pylori infection:: A prospective, randomized study [J].
Sung, JJY ;
Lin, SR ;
Ching, JYL ;
Zhou, LY ;
To, KF ;
Wang, RT ;
Leung, WK ;
Ng, EKW ;
Lau, JYW ;
Lee, YT ;
Yeung, CK ;
Chao, W ;
Chung, SCS .
GASTROENTEROLOGY, 2000, 119 (01) :7-14
[26]  
Sung JJY, 2002, GASTROENTEROLOGY, V122, pA170
[27]  
Tepes B, 1999, J PATHOL, V188, P24, DOI 10.1002/(SICI)1096-9896(199905)188:1&lt
[28]  
24::AID-PATH316&gt
[29]  
3.0.CO
[30]  
2-F